These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25913564)

  • 1. Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
    Cipolla D; Froehlich J; Gonda I
    Adv Drug Deliv Rev; 2015 May; 85():e6-7. PubMed ID: 25913564
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: inhaled antimicrobial therapy-Barriers to effective treatment, by J.Weers, Adv. Drug Deliv. Rev. (2014), http://dx.doi.org/ 10.1016/j.addr.2014.08.013.
    de Boer AH; Hoppentocht M
    Adv Drug Deliv Rev; 2015 May; 85():e1-2. PubMed ID: 25913565
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to the comment by de Boer and Hoppentocht on: inhaled antimicrobial therapy - barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():e3-5. PubMed ID: 25913567
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to the comment by Cipolla et al. on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():e8-e10. PubMed ID: 25913566
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled antimicrobial therapy - barriers to effective treatment.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary drug delivery systems for antimicrobial agents: facts and myths.
    Falagas ME; Michalopoulos A; Metaxas EI
    Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
    Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
    Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance--fluoroquinolones and the tiger's tail.
    Tillotson GS; Carroll J; Klugman KP
    J Chemother; 2006 Jun; 18(3):328-30. PubMed ID: 17129847
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled Antibiotics for Ventilator-Associated Infections.
    Palmer LB
    Infect Dis Clin North Am; 2017 Sep; 31(3):577-591. PubMed ID: 28779834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
    Pell DM
    Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled antibiotics for gram-negative respiratory infections.
    Hudson R; Olson Blair B
    Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for antimicrobial therapy of acute upper respiratory tract infections in Taiwan.
    J Microbiol Immunol Infect; 2002 Dec; 35(4):272-3. PubMed ID: 12542257
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial drugs in the treatment of respiratory infections.
    Sen P
    J Indian Med Assoc; 1979 Jul; 73(1):18-20. PubMed ID: 536598
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin.
    Serisier DJ
    Drugs Today (Barc); 2012 May; 48(5):339-51. PubMed ID: 22645722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory infections and antimicrobial therapy.
    Saunders WH
    Otolaryngol Clin North Am; 1970 Jun; 3(2):303-17. PubMed ID: 5006503
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteria in the respiratory tract-how to treat? Or do not treat?
    Prat C; Lacoma A
    Int J Infect Dis; 2016 Oct; 51():113-122. PubMed ID: 27776777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic kinetic and dynamic attributes for community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1202-10. PubMed ID: 11187444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized antibiotics: the past, present and future, with a special emphasis on inhaled colistin.
    Michalopoulos AS
    Expert Opin Drug Deliv; 2012 May; 9(5):493-5. PubMed ID: 22512595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.